Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Chenyang Li, Xun Sun, Kun Zhao, et al.
Dermatology (2021) Vol. 238, Iss. 4, pp. 725-735
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

From Emollients to Biologicals: Targeting Atopic Dermatitis
Lorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10381-10381
Open Access | Times Cited: 56
The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
Aikaterini Tsiogka, Maria Kyriazopoulou, George Kontochristopoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4431-4431
Open Access | Times Cited: 53
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 33
Atopic Dermatitis: Disease Features, Therapeutic Options, and a Multidisciplinary Approach
Liborija Lugović‐Mihić, Jelena Meštrović-Štefekov, Ines Potočnjak, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1419-1419
Open Access | Times Cited: 28
A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
Mircea Tampa, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 19
Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
Farnam Barati Sedeh, Mattias A. S. Henning, Gregor B. E. Jemec, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00764-adv00764
Open Access | Times Cited: 23
Efficacy and safety of topical JAK inhibitors in the treatment of atopic dermatitis in paediatrics and adults: A systematic review
Sara Sadeghi, Nessa Aghazadeh
Experimental Dermatology (2023) Vol. 32, Iss. 5, pp. 599-610
Open Access | Times Cited: 14
Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
Jiao Wang, Tian Ma, Xiaoying Sun, et al.
Heliyon (2025), pp. e42084-e42084
Open Access
Bullous Pemphigoid: A practical approach to diagnosis and management in the modern era
Camille M. Powers, Sach Thakker, Nicholas Gulati, et al.
Journal of the American Academy of Dermatology (2025)
Closed Access
Age and Socioeconomic Deprivation as Key Predictors of Cardiovascular Risk in Patients With Autoimmune Rheumatic Diseases on JAK Inhibitors
Kehinde Sunmboye, B Nguyen Bui
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 3
Closed Access
Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives
Dong‐Ho Nahm
Life (2023) Vol. 13, Iss. 8, pp. 1674-1674
Open Access | Times Cited: 12
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain
Rosa María Romero Jiménez, Pedro Herranz, Minia Campos Domínguez, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 2, pp. 291-302
Open Access | Times Cited: 4
Novel drug delivery systems in topical treatment of atopic dermatitis
Meghna Dabhadkar, Madhur Kulkarni
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Emerging Therapeutic Innovations for Vitiligo Treatment
Weiran Li, Penghao Dong, Guanhua Zhang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 191-191
Open Access
Systematic Literature Review and Network Meta-Analysis of Clinical Efficacy and Safety of Topical Treatments for Patients with Atopic Dermatitis
Hiroyuki Murota, Takeshi Nakahara, Xinyu Wang, et al.
Dermatology and Therapy (2025)
Open Access
Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses
Qingying He, Xin Xie, Qian Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
New and Upcoming Drugs for the Treatment of Vitiligo
Seol Hwa Seong, Sang Ho Oh
Annals of Dermatology (2024) Vol. 36, Iss. 4, pp. 197-197
Open Access | Times Cited: 3
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
Carlos Alves, Ana Penedones, Diogo Mendes, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 4, pp. 830-838
Open Access | Times Cited: 6
Atopic dermatitis in skin of colour. Part 2: considerations in clinical presentation and treatment options
Christian Gan, Satveer K. Mahil, Andrew Pink, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 10, pp. 1091-1101
Open Access | Times Cited: 6
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases
Jasvinder A. Singh
BioDrugs (2023) Vol. 37, Iss. 5, pp. 625-635
Closed Access | Times Cited: 6
Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring
Emek Kocatürk, Sarbjit S. Saini, Christine J. Rubeiz, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 12, pp. 3099-3116
Closed Access | Times Cited: 10
Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives
Elena Niculeț, Carmen Bobeică, Ioana Anca Ștefanopol, et al.
Therapeutics and Clinical Risk Management (2022) Vol. Volume 18, pp. 399-407
Open Access | Times Cited: 9
Diagnosis, assessment and management of atopic dermatitis in children with skin of colour
Christian Gan, Roland Brand, Rachael Foster, et al.
Australian Journal of General Practice (2023) Vol. 52, Iss. 10
Open Access | Times Cited: 4
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
Mariateresa Rossi, Silvia Mariel Ferrucci, Piergiacomo Calzavara‐Pinton, et al.
Advances in Therapy (2024)
Open Access | Times Cited: 1
Negative patch test findings after initiation of upadacitinib: A case report
Meghan L. McPhie, Melanie D. Pratt, Mark G. Kirchhof
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top